TrialThrombosis and haemostasis2021

Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES.

Alexander P Benz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.